Bluejay Diagnostics (BJDX) Return on Capital Employed (2021 - 2026)

Bluejay Diagnostics (BJDX) has 6 years of Return on Capital Employed data on file, last reported at 141.62% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 94.0% year-over-year to 141.62%; the trailing twelve-month figure through Mar 2026 stood at 141.62% (up 94.0% YoY), and the FY2025 full-year result was 120.52%, up 2424.0% from the prior year.
• Return on Capital Employed held at 141.62% in Q1 2026, from 142.32% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 26.33% in Q1 2022 to a low of 291.92% in Q1 2024.
• A 5-year average of 128.64% and a median of 140.02% in 2025 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed tumbled 19985 bps in 2024 and soared 14936 bps in 2025, its largest moves.
• Tracing BJDX's Return on Capital Employed over 5 years: stood at 71.82% in 2022, then plunged by 200 bps to 215.44% in 2023, then soared by 50 bps to 107.09% in 2024, then plunged by 33 bps to 142.32% in 2025, then advanced by 0 bps to 141.62% in 2026.
• Business Quant data shows BJDX's Return on Capital Employed at 141.62% in Q1 2026, 142.32% in Q4 2025, and 155.09% in Q3 2025.